Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LEN | AMCR |
|---|---|---|
| Price | $81.27 | $41.75 |
| Change today | ▼ 0.39% | ▼ 0.26% |
| Market cap | $19.58B | $19.30B |
| Return, 3 months | -6.1% | -3.0% |
| Return, year to date | -19.7% | +4.6% |
| Return, 1 year | -35.3% | +8.2% |
| P/E (TTM) | 15.4 | 17.5 |
| P/B | 0.9 | 1.6 |
| P/E percentile vs own 5y | 100th | 30th |
| Dividend yield | 2.46% | 6.20% |
| Revenue growth (YoY, latest qtr) | -8.7% | +25.9% |
| Net profit growth (YoY) | -52.4% | +1,097.4% |
| Gross margin | 13.8% | 20.0% |
| Operating margin | 5.6% | 9.3% |
| Net margin | 4.1% | 4.7% |
| Return on equity | 5.9% | 9.4% |
| Analyst target vs. price | -2.6% | +17.1% |
| Analyst buy share | 8% | 56% |
| RSI (14) | 49 | 39 |
| 30-day volatility | 35.8% | 22.8% |
| Max drawdown, 1 year | -41.7% | -26.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
